<p>a) Images of CD69 stained T-cells in M− and M+ conditions. Green- CD69, Greenish black- antigen-coated beads. b) Flow cytometry analysis of CD69 and CD25 in the M− and M+ conditions at 3 and 6 hr, respectively. c) Mean fold change in CD69 and CD25 expressing cells in the M+ condition with respect to the M− condition at different time points (N = 3, mean±s.e.m.). **p<0.005. Statistical significance is calculated with respect to the M− sample at each time point. d) Mean fold change in CD69 expressing cells at 3 hr in the M+ condition (with different bead immobilizing forces) with respect to the M− condition (0 pN) (N = 3, mean±s.d.). *p<0.05, **p<0.005. Statistical significance is calculated with respect to 0pN force.</p
<p>PBMCs were stimulated with anti-CD3 mAb. Flow cytometric analysis of CD39, CD73 and CD25 on CD4<s...
<p>(A) Gating strategy on CD4<sup>+</sup> enriched T cells after overnight culture without stimulati...
Representative flow cytometry profile and cumulative data of cells that were mock-treated (red), cha...
<p>Histograms showing the expression of CD25, CD69, CD38 and HLA-DR from gated CD3+CD4+ cell populat...
<p>T cells from seven donors were transfected with the vectors Scr-Vec-GFP(−) (black bars) or Scr-Ve...
<p>After 24 h of sham or burn procedure, skin cells were studied for the activation marker, CD69, by...
<p>SMARTA or 2D2 splenocytes were stimulated with 10 µM antigen for various time points and CD69 (A)...
Additional file 1: Figure S1. Gating strategy to detect CD69+ or CD25+ cells following sAg-mediated ...
Dual CD69 ISH/ICC (A) and dual Notch1 ISH/ICC (B) on naïve and activated lymphocytes via plate-bound...
<p>The fold change of a panel of host gene markers of CD4 T cell activation was assessed pre- and po...
The expression of activation antigens, namely CD25, CD69, CD71, and HLA-DR on T cells from 15 health...
<p>a: Representative flow-cytometry histograms showing the expression of CD69 on CD1d<sup>high</sup>...
<p>(A) Morphologies of human motile and non-motile primary T cells. (B) Surface expression of CD3, C...
<p>(A) Gating scheme to identify CD169<sup>+</sup>IL-7Rα<sup>hi</sup>CCR6<sup>+</sup> cells analyzed...
<p>a) Representative images of CD69 staining and DNA and graph showing fraction of activated cells e...
<p>PBMCs were stimulated with anti-CD3 mAb. Flow cytometric analysis of CD39, CD73 and CD25 on CD4<s...
<p>(A) Gating strategy on CD4<sup>+</sup> enriched T cells after overnight culture without stimulati...
Representative flow cytometry profile and cumulative data of cells that were mock-treated (red), cha...
<p>Histograms showing the expression of CD25, CD69, CD38 and HLA-DR from gated CD3+CD4+ cell populat...
<p>T cells from seven donors were transfected with the vectors Scr-Vec-GFP(−) (black bars) or Scr-Ve...
<p>After 24 h of sham or burn procedure, skin cells were studied for the activation marker, CD69, by...
<p>SMARTA or 2D2 splenocytes were stimulated with 10 µM antigen for various time points and CD69 (A)...
Additional file 1: Figure S1. Gating strategy to detect CD69+ or CD25+ cells following sAg-mediated ...
Dual CD69 ISH/ICC (A) and dual Notch1 ISH/ICC (B) on naïve and activated lymphocytes via plate-bound...
<p>The fold change of a panel of host gene markers of CD4 T cell activation was assessed pre- and po...
The expression of activation antigens, namely CD25, CD69, CD71, and HLA-DR on T cells from 15 health...
<p>a: Representative flow-cytometry histograms showing the expression of CD69 on CD1d<sup>high</sup>...
<p>(A) Morphologies of human motile and non-motile primary T cells. (B) Surface expression of CD3, C...
<p>(A) Gating scheme to identify CD169<sup>+</sup>IL-7Rα<sup>hi</sup>CCR6<sup>+</sup> cells analyzed...
<p>a) Representative images of CD69 staining and DNA and graph showing fraction of activated cells e...
<p>PBMCs were stimulated with anti-CD3 mAb. Flow cytometric analysis of CD39, CD73 and CD25 on CD4<s...
<p>(A) Gating strategy on CD4<sup>+</sup> enriched T cells after overnight culture without stimulati...
Representative flow cytometry profile and cumulative data of cells that were mock-treated (red), cha...